# FDA recall D-0896-2021

> **IntegraDose Compounding Services LLC** · Class II · drug recall initiated 2021-09-17.

## Product

ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1

## Reason for recall

Lack of sterility assurance.

## Distribution

NH, MA, MN

## Key facts

- **Recall number:** D-0896-2021
- **Recalling firm:** IntegraDose Compounding Services LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-09-17
- **Report date:** 2021-10-06
- **Termination date:** 2022-10-02

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Minneapolis, MN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0896-2021

## Citation

> AI Analytics. FDA recall D-0896-2021. Retrieved 2026-07-15 from https://api.ai-analytics.org/recall/D-0896-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*